三维计算机断层扫描在简单与复杂腹主动脉瘤腔内修复术中的应用
单中心回顾性研究纳入2019至2023年138例腹主动脉瘤腔内修复术,27例使用Cydar三维成像、111例未使用,倾向性评分1:1匹配后各27例。单因素分析显示标准腹主动脉瘤腔内修复术各项指标无统计学差异,但使用三维成像组内漏再干预增多(0 vs 6,P=0.043),医师改良腔内修复术亚组对比剂用量减少15%。
要点
- 倾向性评分匹配后各27例,标准腹主动脉瘤腔内修复术各项指标无统计学差异
- 使用Cydar三维成像组内漏再干预为0 vs 6(P=0.043)
- 医师改良腔内修复术亚组对比剂用量减少15%
核心结论
- 三维成像技术有潜力提高腹主动脉瘤腔内修复术对患者和术者的安全性。
- 本研究中标准腹主动脉瘤腔内修复术未见差异,但医师改良腔内修复术对比剂用量减少。
- 需进一步研究以确定使用该新技术行腹主动脉瘤腔内修复术的实际获益。
研究设计与样本
- 单中心回顾性研究,收集2019至2023年所有行腹主动脉瘤腔内修复术的患者。
- 共识别138例独特患者,27例手术使用Cydar三维成像、111例未使用。
- 采用最近邻匹配进行1:1倾向性评分匹配,匹配变量包括年龄、手术紧急程度及手术在手术室或介入放射室进行。
- Cydar三维成像组患者估计评分在对照组患者0.01个标准差内即匹配,最终各27例共54例。
- 行单因素分析,P值小于0.05视为有统计学意义。
主要发现
- 平均住院日6.4天±11.76 vs 4.1±6.03(P=0.372),无统计学差异。
- 动脉瘤大小5.9±1.4 vs 5.9±1.2(P=0.88),无统计学差异。
- 对比剂用量91.3±47.0 mL vs 91.1-33.49(P=9.88),原文此处表述有矛盾。
- 透视时间20.2±17.2分钟 vs 19.5±19.4分钟(P=0.89),无统计学差异。
- 手术时长299.3±177.9分钟 vs 353±191.98分钟(P=0.279),无统计学差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aneurysm repair (EVAR) success depends on imaging technology both in the planning and operative phases. Endovascular repair requires intravenous contrast and radiation exposure to the patient as well as radiation exposure to the operator. Recent developments in imaging technology attempt to merge preoperative imaging with intraoperative imaging to improve the efficiency and accuracy of EVAR. The Cydar 3-dimensional (3D) imaging system combines the preoperative and intraoperative imaging during the operation. We aim to investigate the use of the Cydar 3D imaging system during EVAR compared to conventional methods. METHODS: Retrospective review of all patients undergoing an EVAR at a single quaternary vascular center from 2019-2023 was collected. This cohort was divided into 2 groups: (1) repair using Cydar 3D imaging or (2) repair without Cydar 3D imaging. Overall, 138 unique patients were identified with 27 operations using Cydar 3D imaging and 111 operations without Cydar 3D imaging. We performed a 1-to-1 propensity score-matched analysis using nearest-neighbor matching for variables including age, case urgency, and if the case was performed in the operative room or interventional radiology room. A match occurred when a patient in the Cydar 3D imaging group had an estimated score within 0.01 standard deviations of a patient in the control group. From this, we paired 27 from each cohort for a total of 54 patients. Demographic data included length of stay in days, contrast volume (mL), fluoroscopy time (min), procedure length (mins), mortality, and blood loss (mL). Univariate analyses were performed and a P value less than 0.05 was considered statistically significant. RESULTS: A total of 54 vascular patients were analyzed: 27 without the Cydar 3D imaging and 27 with the Cydar 3D imaging. In the univariate analysis, there was no statistical difference in the average length of stay (6.4 days ± 11.76 vs. 4.1 ± 6.03, P = 0.372), aneurysm size (5.9 ± 1.4 vs. 5.9 ± 1.2, P = 0.88), contrast volume in mL (91.3 ± 47.0 vs. 91.1-33.49, P = 9.88), fluoroscopy time in mins (20.2 ± 17.2 vs. 19.5 ± 19.4, P = 0.89), procedure length (299.3 ± 177.9 vs. 353 ± 191.98, P = 0.279), and blood loss in mL (513.8 ± 791 vs. 353 ± 191.98, P = 0.594). There was an increase in reintervention for endoleaks in the group with use of Cydar 3D imaging (0 vs. 6, P = 0.043). A subanalysis of patients undergoing physician-modified EVARs did show a 15% reduction in the contrast volume used. CONCLUSIONS: The use of 3D imaging technology has the potential to increase the safety of EVAR to both patients and operators. In our study, we did not find any difference in standard EVARs; however, there was a contrast use decrease in physician-modified EVARs. Further studies will need to be performed to determine the realized benefit from performing EVARs using this new technology.
引用
- Malkoc A, Gnanadev R, Shoemaker HB, et al. The Use of Advanced Three-Dimensional Computed Tomography During Simple and Complex Endovascular Aortic Aneurysm Repairs. Ann Vasc Surg. 2024. PMID: 38754579. doi:10.1016/j.avsg.2024.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。